Topic: formulation

Develop safe, scalable synthetic routes for small-molecule intermediates and drug substances. Laboratory work covers route scouting, optimisation, impurity identification and analytical characterisation, followed by technology transfer to manufacturing partners and collaboration with formulation and quality specialists.

Supports formulation, manufacturing, delivery technologies and predictive methods that improve therapeutic performance. Proposals must identify a therapeutic payload, target tissue and dosing rationale; computational work requires translational validation. Letters of intent are due 30 October 2026 at noon Eastern time.